Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A polycation-based dental desensitizer is an investigational topical agent designed to treat dentin hypersensitivity. It is formulated with positively charged polymeric compounds (polycations) that interact with exposed dentin surfaces. The mechanism of action involves occluding or sealing open dentinal tubules, thereby reducing the transmission of external stimuli to the pulp and alleviating sensitivity symptoms. This approach aims for rapid and sustained relief from pain associated with exposed dentin due to enamel loss or gingival recession. The product is being evaluated in clinical trials for safety and efficacy compared to established agents such as GLUMA Desensitizer[1][2]. Its primary indication is the management of dentin hypersensitivity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on polycation-based dental desensitizer.